Abbott Laboratories (ABT) Capital Expenditures Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 2.15% |
| 10 | Steris | 21.41 Bn | 20.97 Bn | 697.10 Mn | 8.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64% |
| Dec 31, 2025 | 4.14% |
| Sep 30, 2025 | 2.03% |
| Jun 30, 2025 | 9.82% |
| Mar 31, 2025 | 14.67% |
| Dec 31, 2024 | 5.45% |
| Sep 30, 2024 | 6.44% |
| Jun 30, 2024 | 8.87% |
| Mar 31, 2024 | 0.08% |
| Dec 31, 2023 | 3.60% |
| Sep 30, 2023 | 4.13% |
| Jun 30, 2023 | -7.57% |
| Mar 31, 2023 | 1.82% |
| Dec 31, 2022 | 12.02% |
| Sep 30, 2022 | 5.21% |
| Jun 30, 2022 | -6.79% |
| Mar 31, 2022 | -1.41% |
| Dec 31, 2021 | 9.55% |
| Sep 30, 2021 | 9.20% |
| Jun 30, 2021 | 11.49% |